Possible new Passage BIO shares
PASGDilution
Last raise Oct 9, 2026, 424B3: 0 shares (0.0% of the 3.2M then)
Known so far: no new shares from the prospectus covers read · shelf room about $8.5M · not yet read: warrants, converts, options, ATM.
Shelf room
- Room today about $8.5M
- One third of float $8.5M ($25.4M float, Jun 30, 2025)
- Sold off it, 12 months nothing
How this is worked out
Shelf room about $8.5M on the S-3 of Mar 4, 2024: the baby-shelf rule (public float under $75M) caps sales at one third of the $25.4M public float stated as of Jun 30, 2025, $8.5M, nothing sold off it in the last 12 months. Sources: S-3 Mar 4, 2024, effective Apr 16, 2024 · public float, as of Jun 30, 2025.
What could become new Passage BIO (PASG) shares, from its 10-Q, 10-K, S-3 or 424B filings.
Read so far: the cover share count (3.2M shares, +1% from 3.2M on Aug 7, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.
Shares outstanding
3.2M
Nov 2024 to Aug 2026: from 3.1M to 3.2M. Adjusted for the 1-for-20 reverse split by Aug 7, 2025: each earlier count is divided by the ratio of every split after it.
From the share count on the cover of each 10-Q and 10-K, dated as each cover states.
Follow Passage BIO
New shelves, offerings, 10-Qs and 10-Ks from PASG, explained in plain English when they reach EDGAR.
Watch PASG in the app